About Us
In 2014, ProDeMaCon was founded by Andreas M. Beckhaus. Located in San Francisco, CA, this boutique consulting firm operates globally and offers Product Development and Marketing Consulting services for Pharma, Biotech, and Medical Device industries as well as Private Equity and Academic Institutions.
Andreas M. Beckhaus, Ph.D., President
Andreas is an accomplished global leader with 30 years of broad commercial and development experience in Biotech, Pharmaceuticals and Medical Devices. With a background in pharmacy and a PhD in toxicology, he started his professional career in the Regulatory Affairs department of Bayer Healthcare in Germany. After moving to the U.S., he worked in a number of different functions (Regulatory Affairs, Project Management, Lifecycle Management, Portfolio Management and Marketing) with increasing responsibility, particularly focusing on Biotech and rare diseases. In his last role as Vice President Global Strategic Marketing, he was responsible for the Bayer's second largest brand at the time, a recombinant FVIII product with >€1 billion annual revenue.
After 17 years at Bayer, he further broadened his scope into Medical Devices when becoming Vice President International Marketing at KCI Inc., a global wound-healing company.
In 2014, he started his own consulting business and established ProDeMaCon based on the experience from his diverse experience in multiple international roles. Over the last 8+ years, he worked with several clients of different sizes (from Top 3 Pharma to sell start ups) from around the world
David J. Cady, MBA, Principal Consultant
David has over 30 years of experience in progressive leadership roles in R&D, manufacturing, quality, marketing, sales, customer service and strategic sourcing functions including 20 years with GIBCO, which specializes in providing research reagents and critical raw materials to the pharmaceutical and biotechnology industry, and then 10 years as Head of Global Strategic Sourcing, Direct Materials at Amgen. Responsibilities included partnering with all stakeholders to assure effective supplier selection, management and qualification for critical raw materials supply for Amgen’s global product development and manufacturing operations.
Over the past 6 years, David has been working with a variety of Cell Therapy-based start-up organizations including Celgene, Juno, bluebirdbio, Atara Bio, Allogene, Autolus, and TCR2 Therapeutics to develop and execute strategies to ensure effective material and supplier sourcing, onboarding, and qualification and has successfully supported development and regulatory filing preparation for pivotal trial and commercial Biological License Applications.
David has a BS in Biotechnology from SUNY and an MBA from Canisius College.
Our Expertise
“The only source of knowledge is experience.” Albert Einstein
Among others, ProDeMaCon LLC has special knowledge in:
- Rare diseases
- Hemophilia and blood coagulation
- Blood and Plasma-Derived Products
- Hematology
- Oncology
- Diabetes & glucose monitoring
- Cell Therapy
- Gene Therapy
- Medical Devices & Combination Products
- Wound healing
ProDeMaCon LLC has extensive expertise in:
- Product Launches & Go-to-Market Strategy
- Lifecycle Management
- Project Management
- Business Development
- Pricing & Market Access
- Raw Material & Supplier management
- Regulatory Affairs
- Preclinical & Clinical Development
- Biotech CMC
- Emerging Markets
- European Markets
Examples of current and previous projects can be provided upon request.